These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

806 related items for PubMed ID: 25684082

  • 1. Perspective on prescribing conjugated estrogens/bazedoxifene for estrogen-deficiency symptoms of menopause: a practical guide.
    Palacios S, Currie H, Mikkola TS, Dragon E.
    Maturitas; 2015 Apr; 80(4):435-40. PubMed ID: 25684082
    [Abstract] [Full Text] [Related]

  • 2. Tissue-selective estrogen complexes for postmenopausal women.
    Mirkin S, Komm BS.
    Maturitas; 2013 Nov; 76(3):213-20. PubMed ID: 23849704
    [Abstract] [Full Text] [Related]

  • 3. Tissue-selective agents: selective estrogen receptor modulators and the tissue-selective estrogen complex.
    Pickar JH, Mirkin S.
    Menopause Int; 2010 Sep; 16(3):121-8. PubMed ID: 20956688
    [Abstract] [Full Text] [Related]

  • 4. Development of conjugated estrogens/bazedoxifene, the first tissue selective estrogen complex (TSEC) for management of menopausal hot flashes and postmenopausal bone loss.
    Komm BS, Mirkin S, Jenkins SN.
    Steroids; 2014 Nov; 90():71-81. PubMed ID: 24929044
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Selective estrogen modulators in menopause.
    Gambacciani M.
    Minerva Ginecol; 2013 Dec; 65(6):621-30. PubMed ID: 24346250
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The tissue selective estrogen complex: a novel approach to the treatment of menopausal symptoms.
    Kagan R.
    J Womens Health (Larchmt); 2012 Sep; 21(9):975-81. PubMed ID: 22759213
    [Abstract] [Full Text] [Related]

  • 9. Bazedoxifene/conjugated estrogens for menopausal symptom treatment and osteoporosis prevention.
    Pinkerton JV, Pickar JH, Racketa J, Mirkin S.
    Climacteric; 2012 Oct; 15(5):411-8. PubMed ID: 22853444
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of bazedoxifene/conjugated estrogens for the treatment of menopausal symptoms and effects on metabolic parameters and overall safety profile.
    Lobo RA, Pinkerton JV, Gass MLS, Dorin MH, Ronkin S, Pickar JH, Constantine G.
    Fertil Steril; 2009 Sep; 92(3):1025-1038. PubMed ID: 19635615
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Bazedoxifene/conjugated estrogens (BZA/CE): incidence of uterine bleeding in postmenopausal women.
    Archer DF, Lewis V, Carr BR, Olivier S, Pickar JH.
    Fertil Steril; 2009 Sep; 92(3):1039-1044. PubMed ID: 19635614
    [Abstract] [Full Text] [Related]

  • 14. Conjugated estrogen/bazedoxifene tablets for the treatment of moderate-to-severe vasomotor symptoms associated with menopause.
    Mirkin S, Komm B, Pickar JH.
    Womens Health (Lond); 2014 Mar; 10(2):135-46. PubMed ID: 24601804
    [Abstract] [Full Text] [Related]

  • 15. Effects of bazedoxifene/conjugated estrogens on endometrial safety and bone in postmenopausal women.
    Mirkin S, Komm BS, Pan K, Chines AA.
    Climacteric; 2013 Jun; 16(3):338-46. PubMed ID: 23038989
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of bazedoxifene/conjugated estrogens on the endometrium and bone: a randomized trial.
    Pinkerton JV, Harvey JA, Lindsay R, Pan K, Chines AA, Mirkin S, Archer DF, SMART-5 Investigators.
    J Clin Endocrinol Metab; 2014 Feb; 99(2):E189-98. PubMed ID: 24438370
    [Abstract] [Full Text] [Related]

  • 18. Treating menopausal symptoms with a tissue-selective estrogen complex.
    Levine JP.
    Gend Med; 2011 Apr; 8(2):57-68. PubMed ID: 21536225
    [Abstract] [Full Text] [Related]

  • 19. Relief of vasomotor symptoms with the tissue-selective estrogen complex containing bazedoxifene/conjugated estrogens: a randomized, controlled trial.
    Pinkerton JV, Utian WH, Constantine GD, Olivier S, Pickar JH.
    Menopause; 2009 Apr; 16(6):1116-24. PubMed ID: 19546826
    [Abstract] [Full Text] [Related]

  • 20. Bazedoxifene/conjugated estrogens for managing the burden of estrogen deficiency symptoms.
    Mirkin S, Ryan KA, Chandran AB, Komm BS.
    Maturitas; 2014 Jan; 77(1):24-31. PubMed ID: 24246155
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.